To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Liver Cancer: Clinical Trials
Monday 2nd November 2026

Asked by: Paulette Hamilton (Labour - Birmingham Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to make the UK more competitive for commercial liver cancer trials, including tackling logistical and regulatory barriers.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government has delivered a step change in clinical trial set-up and delivery by cutting unnecessary bureaucracy, standardising processes and freeing up workforce capacity.

Streamlined trials improve patient outcomes and accelerate access to and development of new medicines and therapies, including treatments for liver cancer, while driving global investment into life sciences.

Data published on 21 October shows that the Government has met its target to reduce the time it takes to set up a commercial clinical trial to 150 days or less, as set out in the Life Sciences Sector Plan. The average set-up time for commercial clinical trials in the United Kingdom dropped to 100 days in the three months to March this year, down from 153 in the same period last year. More information is available at the following link:

https://www.gov.uk/government/statistics/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026

The National Cancer Plan for England includes a dedicated chapter on research and innovation, setting out actions to improve access to clinical trials and accelerate the set-up and delivery of cancer clinical trials.


Written Question
Obesity: Disadvantaged
Monday 2nd November 2026

Asked by: Paulette Hamilton (Labour - Birmingham Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of deprivation on obesity; and what steps her Department plans to address this.

Answered by Diana Johnson - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer provided on 13 April in response to Question 123732.


Written Question
Liver Diseases
Monday 19th October 2026

Asked by: Paulette Hamilton (Labour - Birmingham Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what her strategy is for increasing public awareness of the risk factors and early symptoms of liver disease.

Answered by Diana Johnson - Minister of State (Department of Health and Social Care)

I refer the Hon Member to the answer provided on 18 September in response to Question 27776.


Written Question
Maternity Services: Discrimination
Monday 14th September 2026

Asked by: Paulette Hamilton (Labour - Birmingham Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of the number of trusts where maternity services have had culturally sensitive training on racism and discrimination on Black women’s experiences and engagement with maternity care.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

We are rolling out an anti-discrimination programme to all trusts by the end of this year, to be completed by the end of 2027, which will equip leaders and frontline staff to use tried and tested approaches to tackle discriminatory practices. A robust, independent evaluation of this programme has been commissioned and is being undertaken.

This is part of a broader set of actions to tackle the root causes of racism and discrimination. We have also established an inequalities dashboard, to identify areas where specific populations face the greatest disparities, enabling tailored interventions and more equitable support.


Written Question
Cancer: Health Services
Monday 20th July 2026

Asked by: Paulette Hamilton (Labour - Birmingham Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, further to the Answer of 16 June 2026 to Question 8929, if his Department will consult with civil society organisations with expertise relating to rare and less survivable cancers when developing the cancer manuals in order to ensure that they fulfil the National Cancer Plan's aim of reducing disparities in cancer survival.

Answered by Sharon Hodgson

The Department and NHS England continue to work with cancer stakeholders on the implementation of the National Cancer Plan and will discuss the development of cancer manuals with relevant stakeholders.

As set out in our National Cancer Plan, the first wave of manuals will include an equal balance of rare cancers, where survival has been slowest, and the most common cancers. It is in the combination of both points that we will maximise progress against our ambition to reduce disparities in cancer survival.


Written Question
Brain: Tumours
Monday 6th July 2026

Asked by: Paulette Hamilton (Labour - Birmingham Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what data his Department holds on the fresh freezing and storage of brain tumour tissue, including data collected through NHS England’s gap analysis of freezer capacity; and if he will provide the most recent available data by NHS trust on the (a) availability of suitable freezer capacity and (b) proportion of brain tumour patients whose tissue is routinely fresh-frozen and stored following surgery.

Answered by Sharon Hodgson

NHS England has completed a gap analysis of the need for freezer capacity and is looking at how to support services to provide an equitable expansion of that capacity. 

The Department and NHS England will work with professional bodies, including the Royal College of Pathologists, to review tissue retention guidance and consent processes.

The Department is looking at ways to support trusts to expand freezer capacity, and will provide an update on this in the autumn.

There are no plans to publish the full gap analysis. The data is management information which is not routinely published.


Written Question
Pharmacy: Private Finance Initiative
Monday 5th January 2026

Asked by: Paulette Hamilton (Labour - Birmingham Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will review financial relief for pharmacies on PFI estates, including rent-subsidy schemes and a statutory cap on PFI rents for NHS pharmacy contractors.

Answered by Stephen Kinnock - Secretary of State for Wales

For 2025/26, funding for the core community pharmacy contractual framework was increased to £3.1 billion. This represented the largest uplift in funding of any part of the National Health Service at the time, over 19% across 2024/25 and 2025/26. As is custom and practice, the Department will consult Community Pharmacy England on any proposed changes to future reimbursement and remuneration of pharmacy contractors.

Community pharmacies are private businesses that provide NHS services. Pharmacies also receive private, non-NHS, income, which contributes to business expenses such as rent.

Health Private Finance Initiative (PFI) contracts are not held by the Department, they are held between the local NHS trust and their respective Private Finance Company. The operational Health PFI contracts included the design, build and maintenance of the building, including facilities management and lifecycle, over the life of the contract. Any arrangements in respect of letting specific areas of a PFI Hospital to third party occupants, including a pharmacy, will be agreed on a case-by-case basis at a local level.


Written Question
Pharmacy: Finance
Monday 5th January 2026

Asked by: Paulette Hamilton (Labour - Birmingham Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will consider NHS funding adjustments for pharmacies to offset increases in National Minimum Wage and employer National Insurance.

Answered by Stephen Kinnock - Secretary of State for Wales

For 2025/26, funding for the core community pharmacy contractual framework was increased to £3.1 billion. This represented the largest uplift in funding of any part of the National Health Service at the time, over 19% across 2024/25 and 2025/26. As is custom and practice, the Department will consult Community Pharmacy England on any proposed changes to future reimbursement and remuneration of pharmacy contractors.

Community pharmacies are private businesses that provide NHS services. Pharmacies also receive private, non-NHS, income, which contributes to business expenses such as rent.

Health Private Finance Initiative (PFI) contracts are not held by the Department, they are held between the local NHS trust and their respective Private Finance Company. The operational Health PFI contracts included the design, build and maintenance of the building, including facilities management and lifecycle, over the life of the contract. Any arrangements in respect of letting specific areas of a PFI Hospital to third party occupants, including a pharmacy, will be agreed on a case-by-case basis at a local level.


Written Question
Pharmacy: Sustainable Development
Monday 5th January 2026

Asked by: Paulette Hamilton (Labour - Birmingham Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to help support the sustainability of NHS pharmacies operating on PFI sites.

Answered by Stephen Kinnock - Secretary of State for Wales

For 2025/26, funding for the core community pharmacy contractual framework was increased to £3.1 billion. This represented the largest uplift in funding of any part of the National Health Service at the time, over 19% across 2024/25 and 2025/26. As is custom and practice, the Department will consult Community Pharmacy England on any proposed changes to future reimbursement and remuneration of pharmacy contractors.

Community pharmacies are private businesses that provide NHS services. Pharmacies also receive private, non-NHS, income, which contributes to business expenses such as rent.

Health Private Finance Initiative (PFI) contracts are not held by the Department, they are held between the local NHS trust and their respective Private Finance Company. The operational Health PFI contracts included the design, build and maintenance of the building, including facilities management and lifecycle, over the life of the contract. Any arrangements in respect of letting specific areas of a PFI Hospital to third party occupants, including a pharmacy, will be agreed on a case-by-case basis at a local level.


Written Question
Health Services: Infrastructure and Planning Permission
Monday 5th January 2026

Asked by: Paulette Hamilton (Labour - Birmingham Erdington)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will conduct a review of local planning and healthcare infrastructure for villages and local hub–type plans, including PFI estates.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

Planning regulation and approval is a matter for the Ministry of Housing, Communities and Local Government. The National Health Service operates in accordance with published planning guidance.

However, we recognise delivering high-quality NHS healthcare services requires the right infrastructure in the right places. Integrated care boards have developed infrastructure strategies to create a long-term plan for future healthcare estate requirements and investment for each local area and its needs.

These strategies help take the existing and future general practice and primary care estate into account when considering how best to deliver local services, including the development of a Neighbourhood Health Service.